Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Neurogene Announces Updates to Pediatric Gene Therapy Clinical Trial
Neurogene Announces NGN-401 Gene Therapy for Rett Syndrome Selected by ...
Neurogene Announces First Patient Dosed in High-Dose Cohort of NGN-401 ...
Neurogene Announces Interim Results from Gene Therapy Clinical Trial
Neurogene Announces Trial Design for Embolden™ Study of NGN-401 Gene ...
Neurogene Provides Update on NGN-401 Gene Therapy Clinical Trial for ...
Neurogene gives first clinical trial update of 2026 and lays out plans ...
FDA Selects Neurogene Rett Program for START Pilot Program
Neurogene Doses First Participant in Embolden™ Registrational Trial of ...
Neurogene announce that the FDA have cleared their Rett gene therapy ...
Neurogene Announces Expansion and Plans for More Rapid Patient ...
Neurogene Releases Update on NGN-401 Clinical Trial High Dose
Neurogene Receives FDA Approval for Gene Replacement Clinical Trial for ...
Neurogene is excited to announce the FDA clearance of our ...
Neurogene doses first two children in gene therapy clinical trial
Neurogene Shares Key Information on Gene Therapy Clinical Trial with ...
Details on Neurogene Gene Therapy Trial Now on ClinicalTrial.gov | Rett ...
Neurogene - Neurogene is excited to announce the FDA has cleared our ...
Neurogene Announces Addition to Russell 3000® Index
Neurogene doses first paediatric patients in US clinical trial of NGN ...
Neurogene Announces First Rett Syndrome Gene Therapy Trial in U.S ...
Neurogene Reports 35 Milestones Gained in Rett Gene Therapy Trial ...
Neurogene Update: NGN-401: A Self-regulating Gene Therapy for Rett ...
Neurogene Unveils Remarkable Trial Results in Rett Syndrome
Neurogene Merge with Neoleukin Therapeutics | citybiz
Today, we announced that Neurogene management will present at three ...
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the ...
Neurogene Launches With $68.5 Million to Advance Gene Therapies for ...
Neurogene | Developing Gene Therapies for Patients & Families
Edinburgh Innovations | Neurogene
Neurogene Merges with Neoleukin
Positive update on Neurogene Rett gene therapy program | Reverse Rett
Neurogene Advances NGN-401 Gene Therapy for Rett Syndrome with Positive ...
Neurogene | Rett Syndrome Research Trust
FDA picks Denali, Neurogene and more for rare disease program
Encouraging update from Neurogene NGN-401 Gene Therapy Clinical Trial ...
Neurogene Expands Gene Therapy Clinical Trial for Rett Syndrome ...
Neurogene Doses First Patient in NGN-401 Rett Trial, 12 Sites | NGNE ...
Neurogene Org Chart + Executive Team
Neurogene to Present Interim Clinical Data from Phase 1/2 Trial of NGN ...
Neurogene Reports Interim P-I/II Trial Results on NGN-401 to Treat ...
Neurogene Dysphagie (Labeit) ǀ UKD
Neurogene Presents Favorable Safety Data from Phase 1/2 Trial of NGN ...
Neurogene Rings the Opening Bell | Neurogene Inc.
Neurogene - 2026 Company Profile, Funding, Competitors & Financials ...
About Neurogene – Neurogene Inc.
Neurogene 30 bags | The Wellness Tree
Neurogene Plans Embolden Dosing in Q4 2025 at 13 Sites | NGNE Stock News
What’s next for brain-directed gene therapy after death in Neurogene ...
Neurogene Reports First Quarter 2024 Financial Results and Highlights ...
Neurogene (NGNE) - P/E ratio
Community FAQs about recent patient death in Neurogene gene therapy ...
Neurogene Reports Positive Interim Data from NGN-401 Gene Therapy ...
Neurogene Reports Adverse Event in Gene Therapy Trial for Rett Syndrome
Neurogene announcement: Key takeaways | Reverse Rett
NEUROGENE | Qualidade em Exames Genéticos
Our Technology – Neurogene Inc.
Laboratório Neurogene | Florianópolis SC
Neurogene - LifeScienceHistory.com
Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 ...
Neurogene aplica dosagem da terapia genética NGN-401 nas duas primeiras ...
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Neurogene Inc. - AnnualReports.com
Neurogene to Participate in Upcoming Conferences | Business Wire
Neurogene announces treatment intended to reverse HLH associated with ...
Neurogene Announces First Patient Enrolled in Natural History Study ...
Neurogene (NGNE) - P/S ratio
Exciting News from Taysha and Neurogene - Girl Power 2 Cure
Neurogene logo in transparent PNG and vectorized SVG formats
Neurogene Reports First Quarter 2025 Financial Results and Highlights ...
Neurogene Inc (NGNE) Stock Price & News - Google Finance
Neurogene apresentou dados de segurança favoráveis do seu teste de ...
Neurogene Reports Positive Interim Efficacy Data from First Four Low ...
Frontiers in Neurogenesis
Neurogene’s Revolutionary Gene Therapy for Rett Syndrome: Exciting Data ...
NeuroGen (Noxygen) 60 капс - купить по низкой цене
FDA Selects Neurogene’s NGN-401 for Innovative Rett Syndrome Therapy ...
Understanding neurogenic inflammation - Genoskin
Neurogene’s Triumphant Progress in NGN-401 Gene Therapy
DAYBUE in the Real World | International Rett Syndrome Foundation
Promising Safety Results from Neurogene's Phase 1/2 Study of NGN-401 ...
Neurogene’s NG-401 Gets RMAT Designation for Rett Syndrome Treatment
Adult Neurogenesis: A Story Ranging from Controversial New Neurogenic ...
crmr-neurogene | BRAIN-TEAM
基因药物开发生物技术公司：Neurogene Inc.(NGNE) | 美股之家
Future of Gene Therapy: Neurogene’s Rett Syndrome Trial and AAV Challenges
Neurogenic Shock Dalchaebi
Neurogenic response. Schematic design of the mechanisms involved in the ...
基因药物开发生物技术公司：Neurogene Inc.(NGNE) | 美股之家 - 港股美股开户投资百科全书
Neurogene’s NGN-401 gene therapy scores well in Rett syndrome ...
Research Spotlight - Girl Power 2 Cure
IND获批 | Neurogene基因治疗药物NGN-101的IND申请获FDA批准医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
RettEd Days | International Rett Syndrome Foundation
